Hanmi Pharmaceutical., Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hanmi Pharmaceutical., Company Limited with three other
companies in this sector in South Korea:
Daewoong Company Limited
sales of 1.23 trillion Korean Won [US$1.03 billion]
of which 113%
was Medicinal Manufacturing & Selling),
Kwang Dong Pharmaceutical Company Limited
(1.18 trillion Korean Won [US$987.84 million]
of which 42%
was MRO), and
Daewoong Pharmaceutical Company Limited
(1.03 trillion Korean Won [US$863.30 million]
of which 103%
was Medicine Manufacture&Sale).
Hanmi Pharmaceutical., Company Limited reported sales of 1.02 trillion Korean Won (US$850.36 million)
December of 2018.
increase of 10.8%
versus 2017, when the company's sales were 916.59 billion Korean Won.
Sales of Medicine saw an increase
13.0% in 2018, from
696.79 billion Korean Won to 787.42 billion Korean Won.
Not all segments of Hanmi Pharmaceutical., Company Limited experienced an increase in sales in 2018:
sales of Raw Medicine fell 79.0% to 1.24 billion Korean Won.
(However, this segment's sales were only a very small portion of the company's overall sales).